XBiotech Inc.
XBITNasdaqCIK 1626878HealthcareFiscal year ends Dec 31
Reports and events: 136 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2021-03-1616:28 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001171843-21-001828 |
| 2020-11-0917:28 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001171843-20-007826 |
| 2020-08-1017:24 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001171843-20-005794 |
| 2020-06-2913:14 ET | 8-K | 5.07 Shareholder vote results | 0001171843-20-004608 |
| 2020-05-1117:23 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001171843-20-003601 |
| 2020-04-2913:50 ET | DEF 14A | Proxy statementPeriod 2020-06-26 | 0001171843-20-002999 |
| 2020-03-1617:24 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001171843-20-001761 |
| 2019-12-3017:08 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-19-008353 |
| 2019-12-0916:28 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-19-008024 |
| 2019-11-1211:47 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001171843-19-007437 |
| 2019-08-0915:01 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001171843-19-005378 |
| 2019-07-1612:36 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-19-004604 |
| 2019-06-2013:16 ET | 8-K | 5.07 Shareholder vote results | 0001171843-19-004081 |
| 2019-06-0316:48 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-19-003792 |
| 2019-05-3016:50 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-19-003712 |
| 2019-05-3016:19 ET | 8-K | 1.02 Termination of a material agreement | 0001171843-19-003710 |
| 2019-05-0914:37 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001171843-19-003199 |
| 2019-05-0117:20 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001171843-19-002822 |
| 2019-04-3012:51 ET | DEF 14A | Proxy statementPeriod 2019-06-19 | 0001171843-19-002757 |
| 2019-04-0316:10 ET | 8-K | 1.02 Termination of a material agreement | 0001171843-19-002224 |
| 2019-03-1513:09 ET | 10-K/A | Annual report, amendedPeriod 2018-12-31 | 0001171843-19-001758 |
| 2019-03-1420:00 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001171843-19-001708 |
| 2018-10-3115:48 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001171843-18-007413 |
| 2018-10-2412:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-18-007152 |
| 2018-09-0518:34 ET | 10-K/A | Annual report, amendedPeriod 2017-12-31 | 0001171843-18-006389 |
| 2018-09-0517:50 ET | 10-Q/A | Quarterly report, amendedPeriod 2018-03-31 | 0001171843-18-006385 |
| 2018-08-0912:46 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001171843-18-005920 |
| 2018-07-3115:32 ET | 10-K/A | Annual report, amendedPeriod 2017-12-31 | 0001171843-18-005559 |
| 2018-07-3114:30 ET | 10-Q/A | Quarterly report, amendedPeriod 2018-03-31 | 0001171843-18-005556 |
| 2018-06-2114:18 ET | 8-K | 5.07 Shareholder vote results | 0001171843-18-004776 |
| 2018-05-0815:23 ET | 10-Q | Quarterly reportPeriod 2018-03-31 | 0001171843-18-003654 |
| 2018-04-3016:22 ET | DEF 14A | Proxy statementPeriod 2018-04-30 | 0001171843-18-003188 |
| 2018-04-1115:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001171843-18-002645 |
| 2018-03-2312:12 ET | 8-K | 8.01 Other events | 0001171843-18-002228 |
| 2018-03-2216:28 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001171843-18-002197 |
| 2018-03-1616:15 ET | 10-K | Annual reportPeriod 2017-12-31 | 0001171843-18-002043 |
| 2018-03-0117:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001171843-18-001608 |
| 2018-01-1918:29 ET | 8-K | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors | 0001171843-18-000446 |
| 2018-01-0512:14 ET | 8-K | 8.01 Other events | 0001171843-18-000201 |
| 2017-11-2207:12 ET | 8-K | 8.01 Other events | 0001171843-17-007231 |
| 2017-11-0915:37 ET | 10-Q | Quarterly reportPeriod 2017-11-02 | 0001171843-17-006828 |
| 2017-09-1518:12 ET | 8-K | 8.01 Other events | 0001171843-17-005552 |
| 2017-08-0816:51 ET | 10-Q | Quarterly reportPeriod 2017-06-30 | 0001171843-17-004856 |
| 2017-06-2011:44 ET | 8-K | 5.07 Shareholder vote results | 0001171843-17-003698 |
| 2017-06-0915:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-17-003574 |
| 2017-05-1816:29 ET | 8-K | 8.01 Other events | 0001171843-17-003181 |
| 2017-05-1016:35 ET | 10-Q | Quarterly reportPeriod 2017-03-31 | 0001171843-17-002928 |
| 2017-04-2817:06 ET | DEF 14A | Proxy statementPeriod 2017-06-19 | 0001171843-17-002419 |
| 2017-04-2811:58 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-17-002408 |
| 2017-04-2118:51 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-17-002235 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 18:14 ET. Listed shows no prices and gives no investment advice.